Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1
Abstract
Background and purpose To report on a Quality assessment (QA) of Skagen Trial 1, exploring hypofractionation for breast cancer patients with indication for regional nodal radiotherapy. Material and methods Deviations from protocol regarding target volume delineations and dose parameters (Dmin, Dmax, D98%, D95% and D2%) from randomly selected dose plans were assessed. Target volume delineation according to ESTRO guidelines was obtained through...
Paper Details
Title
Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1
Published Date
May 1, 2017
Journal
Volume
123
Issue
2
Pages
282 - 287
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History